Skip to main content

Advertisement

Log in

An insight into in vitro strategies for bioproduction of isoflavones

  • Review
  • Published:
Plant Biotechnology Reports Aims and scope Submit manuscript

Abstract

Isoflavones (ISF) are potent secondary metabolites, widely distributed among the members of the Fabaceae family. They have a multitude of biological functions in plants, animals, and humans. Most of the functions exhibited by isoflavones are highly beneficial to human beings. Benefits mainly include lowering cardiovascular diseases, reducing menopausal symptoms, and decreasing the risk of hormone-related cancers. Therefore, this potent compound has emerged as a promising possibility for making medicines and has grabbed the pharmaceutical industry's attention. Nowadays, many isoflavone-based products are manufactured commercially as food supplements, and their demand is drastically increasing globally. Numerous in vitro studies have successfully synthesized value-added metabolites that possess a vast number of industrial applications. Production of isoflavones within the plants depends on several biological and environmental conditions. Hence, in vitro cultures provide an alternate source to recover these compounds independent of environmental factors and limited bio-resources. Plant organ cultures could be highly recommended as a reliable platform for synthesizing plant-based pharmaceutically active isoflavones. Moreover, biotechnological approaches, such as elicitation and precursor feeding, can eventually promote the yield and increase these metabolites' production. This review initially outlines information regarding the source, structure, synthesis, and diverse roles of isoflavones. Later, this paper describes different plant organ cultures for the in vitro production of isoflavones and highlights elicitation strategies as well as metabolic engineering work to enhance production.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Download references

Acknowledgements

The authors are thankful to the Department of Science and Technology (DST), Ministry of Science and Technology, Government of India, (Reference no: SR/WOS-A/LS-405/2018) for the financial support provided to Vidya Nandakumar to carry out the present work.

Author information

Authors and Affiliations

Authors

Contributions

MA: conception and design of the article; NV: wrote the manuscript with the assistance of MA; KS and JH: preparation of tables; KK and JS: conceptualization and preparation of figures; PG, RR, and AU: critical reviewing of the manuscript.

Corresponding author

Correspondence to Muthukrishnan Arun.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vidya, N., Saravanan, K., Halka, J. et al. An insight into in vitro strategies for bioproduction of isoflavones. Plant Biotechnol Rep 15, 717–740 (2021). https://doi.org/10.1007/s11816-021-00711-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11816-021-00711-3

Keywords

Navigation